HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms.

AbstractBACKGROUND:
B-type natriuretic peptide (BNP) is an endogenous peptide produced under physiological and pathological conditions mainly by ventricular myocytes. It has natriuretic, diuretic, blood pressure-lowering, and antifibrotic actions that could mediate cardiorenal protection in cardiovascular diseases. In the present study, we used BNP gene transfer to examine functional and structural effects of BNP on left ventricular (LV) remodeling.
METHODS AND RESULTS:
Human BNP was overexpressed by using adenovirus-mediated gene delivery in normal rat hearts and in hearts during the remodeling process after infarction and in an experimental model of angiotensin II-mediated hypertension. In healthy hearts, BNP gene delivery into the anterior wall of the LV decreased myocardial fibrosis (P<0.01, n=7 to 8) and increased capillary density (P<0.05, n=7 to 8) associated with a 7.3-fold increase in LV BNP peptide levels. Overexpression of BNP improved LV fractional shortening by 22% (P<0.05, n=6 to 7) and ejection fraction by 19% (P<0.05, n=6 to 7) after infarction. The favorable effect of BNP gene delivery on cardiac function after infarction was associated with normalization of cardiac sarcoplasmic reticulum Ca(2+)-ATPase expression and phospholamban Thr17-phosphorylation. BNP gene delivery also improved fractional shortening and ejection fraction in angiotensin II-mediated hypertension as well as decreased myocardial fibrosis and LV collagen III mRNA levels but had no effect on angiogenesis or Ca(2+)-ATPase expression and phospholamban phosphorylation.
CONCLUSIONS:
Local intramyocardial BNP gene delivery improves cardiac function and attenuates adverse postinfarction and angiotensin II-induced remodeling. These results also indicate that myocardial BNP has pleiotropic, context-dependent, favorable actions on cardiac function and suggest that BNP acts locally as a key mechanical load-activated regulator of angiogenesis and fibrosis.
AuthorsAnne-Mari Moilanen, Jaana Rysä, Erja Mustonen, Raisa Serpi, Jani Aro, Heikki Tokola, Hanna Leskinen, Aki Manninen, Jouko Levijoki, Olli Vuolteenaho, Heikki Ruskoaho
JournalCirculation. Heart failure (Circ Heart Fail) Vol. 4 Issue 4 Pg. 483-95 (Jul 2011) ISSN: 1941-3297 [Electronic] United States
PMID21558448 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Collagen Type III
  • Organothiophosphorus Compounds
  • Angiotensin II
  • Natriuretic Peptide, Brain
  • phosfolan
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
Topics
  • Adenoviridae (genetics)
  • Angiotensin II (adverse effects)
  • Animals
  • Collagen Type III (metabolism)
  • Disease Models, Animal
  • Fibrosis (physiopathology)
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Humans
  • Hypertension (chemically induced, complications, physiopathology)
  • Ligation
  • Male
  • Myocardial Infarction (complications, etiology, physiopathology)
  • Natriuretic Peptide, Brain (genetics, physiology)
  • Neovascularization, Physiologic (physiology)
  • Organothiophosphorus Compounds (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases (metabolism)
  • Ventricular Dysfunction, Left (etiology, physiopathology, therapy)
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: